top of page

LATEST NEWS

August 2023

  • All the links have been checked and are working properly.

  • The number of current clinical trials was updated accordingly:

    • MORAb-202: [2+] to [3+] under Europe  Active Clinical Trials

    • BT5528 & BT8009: Studies for both are categorized under Phase 1 AND 2 per clinicaltrials.gov and company's website. Both compounds added to Phase 2 table.

June 2023:

  • All the links have been checked and are working properly.

  • The number of current clinical trials was updated accordingly:

    • RC-88: [2+] to [3+] under US  Active Clinical Trials​

  • Plocabulin (PM184) was removed as there are currently no active trials.

April 2023:

  •  All the links have been checked and are working properly.

  • The number of current clinical trials was updated accordingly:

    • Ladiratuzumab vedotin (SGN-LIV1A): [5+] to [4+] under US – Active Clinical Trials
    • Bryostatin: [1+] to None under US – Active Clinical Trials
    • MORAb-202: [2+] to [3+] under US – Active Clinical Trials; None to [2+] under Europe – Active Clinical Trials
    • MRG003: [5+] to [6+] under US – Active Clinical Trials
    • RC-88: [1+] to [2+] under US – Active Clinical Trials
    • STI-6129: [4+] to [5+] under US – Active Clinical Trials
    • ARX-788: None to [1+] under Europe – Active Clinical Trials
    • Upifitamab rilsodotin (XMT-1536): [2+] to [3+] under US – Active Clinical Trials; None to [1+] under Europe – Active Clinical Trials

 

February 2023:

  • All the links have been checked and are working properly.

  • The number of current clinical trials was updated accordingly.

  • Compound name and molecular target has been updated for MORAb-202

  • Link has been added for chemical class for XMT-1536
     

December 2022:

  • All the links have been checked and were working properly, except links addressing compounds in Chinese clinical trials. We are working with Dr. Jinbo Yang's group to update these links.

  • The number of current clinical trials was updated accordingly.

  • Links have been added for chemical class for several compounds.

  • Link has been added for compound name for MRG003

  • 4 new compounds were added: RC-88, STI-6129, ARX-788, and Upifitamab rilsodotin (XMT-1536).

September 2022: 

Approved Marine Drugs
© 2021-2023 Marine Pharmacology
© 2021-2023 Marine Pharmacology
bottom of page